These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 8103122

  • 1. [PCNA (proliferating cell nuclear antigen) expression in adenocarcinomas < 2 cm of the peripheral lung].
    Koshikawa T, Nakamura S, Kitoh K, Hayashi K, Suyama M, Kunishima K.
    Rinsho Byori; 1993 Jun; Suppl 94():113-24. PubMed ID: 8103122
    [No Abstract] [Full Text] [Related]

  • 2. Proliferating cell nuclear antigen expression and argyrophilic nucleolar organizer regions as factors influencing prognosis of surgically treated lung cancer patients.
    Ishida T, Kaneko S, Akazawa K, Tateishi M, Sugio K, Sugimachi K.
    Cancer Res; 1993 Oct 15; 53(20):5000-3. PubMed ID: 8104690
    [Abstract] [Full Text] [Related]

  • 3. [Flow cytometric techniques for measurement of proliferating cell nuclear antigen (PCNA)].
    Ichikawa A, Shimamura K, Koyama Y.
    Nihon Rinsho; 1992 Oct 15; 50(10):2343-8. PubMed ID: 1360029
    [Abstract] [Full Text] [Related]

  • 4. [Evaluation of AgNORs in lung cancer].
    Abe S.
    Rinsho Byori; 1993 Jun 15; Suppl 94():104-12. PubMed ID: 8361003
    [No Abstract] [Full Text] [Related]

  • 5. [Contribution of proliferating cell nuclear antigen to prognostic evaluation of carcinomas of the maxillary sinus].
    Mikuni H, Fukuda S, Furuta Y, Takasu T, Nagahashi T, Inuyama Y.
    Nihon Jibiinkoka Gakkai Kaiho; 1992 Dec 15; 95(12):1944-9. PubMed ID: 1362772
    [Abstract] [Full Text] [Related]

  • 6. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
    Oyama T, Osaki T, Nose N, Ichiki Y, Inoue M, Imoto H, Yoshimatsu T, Kodate M, Uramoto H, Mizoue T, Yano K, Yasumoto K.
    Anticancer Res; 2000 Dec 15; 20(1B):505-10. PubMed ID: 10769714
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Proliferating nuclear antigen (PCNA) as a prognostic factor of squamous cell carcinoma of the oesophagus.
    Dabrowski A, Szumiło J, Brajerski G, Wallner G.
    Ann Univ Mariae Curie Sklodowska Med; 2001 Dec 15; 56():59-67. PubMed ID: 11977365
    [Abstract] [Full Text] [Related]

  • 9. Tumor histology affects the accuracy of clinical evaluative staging in primary lung cancer.
    Funakoshi Y, Maeda H, Takeda S, Nojiri T, Kawamura T.
    Lung Cancer; 2010 Nov 15; 70(2):195-9. PubMed ID: 20621386
    [Abstract] [Full Text] [Related]

  • 10. Neural networks as a prognostic tool for patients with non-small cell carcinoma of the lung.
    Bellotti M, Elsner B, Paez De Lima A, Esteva H, Marchevsky AM.
    Mod Pathol; 1997 Dec 15; 10(12):1221-7. PubMed ID: 9436967
    [Abstract] [Full Text] [Related]

  • 11. The expression of proliferating cell nuclear antigen (PCNA) and p 53 protein correlate with prognosis of patients with oral squamous cell carcinoma.
    Kurokawa H, Yamashita Y, Takeda S, Miura K, Murata T, Kajiyama M.
    Fukuoka Igaku Zasshi; 1999 Jan 15; 90(1):6-13. PubMed ID: 10087668
    [Abstract] [Full Text] [Related]

  • 12. Prognostic implications of calbindin-D28k expression in lung cancer: analysis of 452 cases.
    Castro CY, Stephenson M, Gondo MM, Medeiros LJ, Cagle PT.
    Mod Pathol; 2000 Jul 15; 13(7):808-13. PubMed ID: 10912942
    [Abstract] [Full Text] [Related]

  • 13. [Application of image analysis and flow cytometry for lung cancer cytology].
    Konaka C, Kato H, Ikeda N, Shimizu E, Kamura T.
    Rinsho Byori; 1993 Jun 15; Suppl 94():66-75. PubMed ID: 8103125
    [No Abstract] [Full Text] [Related]

  • 14. Relevance of proliferative and pro-apoptotic factors in non-small-cell lung cancer for patient survival.
    Volm M, Koomägi R.
    Br J Cancer; 2000 May 15; 82(10):1747-54. PubMed ID: 10817513
    [Abstract] [Full Text] [Related]

  • 15. Prognostic values of stromal proportion and PCNA, Ki-67, and p53 proteins in patients with resected adenocarcinoma of the lung.
    Demarchi LM, Reis MM, Palomino SA, Farhat C, Takagaki TY, Beyruti R, Saldiva PH, Capelozzi VL.
    Mod Pathol; 2000 May 15; 13(5):511-20. PubMed ID: 10824922
    [Abstract] [Full Text] [Related]

  • 16. Differences in the prognostic implications of vascular invasion between lung adenocarcinoma and squamous cell carcinoma.
    Usui S, Minami Y, Shiozawa T, Iyama S, Satomi K, Sakashita S, Sato Y, Noguchi M.
    Lung Cancer; 2013 Dec 15; 82(3):407-12. PubMed ID: 24094286
    [Abstract] [Full Text] [Related]

  • 17. Characteristics and prognosis of patients after resection of nonsmall cell lung carcinoma measuring 2 cm or less in greatest dimension.
    Okada M, Sakamoto T, Nishio W, Uchino K, Tsubota N.
    Cancer; 2003 Aug 01; 98(3):535-41. PubMed ID: 12879471
    [Abstract] [Full Text] [Related]

  • 18. Bromodeoxyuridine uptake and proliferating cell nuclear antigen expression throughout the colorectal tumor sequence.
    Risio M, Candelaresi G, Rossini FP.
    Cancer Epidemiol Biomarkers Prev; 1993 Aug 01; 2(4):363-7. PubMed ID: 8102291
    [Abstract] [Full Text] [Related]

  • 19. [Correlation between magnetic resonance imaging findings and proliferating cell nuclear antigen expression in peripheral lung cancer].
    Xiang ZM, Hu YS, Zhao SY, Tan LL, Li ZH.
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Dec 01; 28(12):2230-2. PubMed ID: 19114366
    [Abstract] [Full Text] [Related]

  • 20. Prognostic role of proliferating cell nuclear antigen in lung cancer: an immunohistochemical analysis.
    Caputi M, Esposito V, Groger AM, Pacilio C, Murabito M, Dekan G, Baldi F, Wolner E, Giordano A.
    In Vivo; 1998 Dec 01; 12(1):85-8. PubMed ID: 9575430
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.